Increased PI3K-AKT-mTOR signaling resulting from these mutations can increase HIF-1α synthesis1 and may render cancer cells resistant to anti-HIF-1α strategies, such as those targeting receptor tyrosine kinases4, 24. The gene discussed is MTOR; the disease is cancer.